Table 2.
Headache attributed to a substance or its withdrawal.
| Headache attributed to use of or exposure to a substance |
| Nitric oxide (NO) donor-induced headache |
| Phosphodiesterase (PDE) inhibitor-induced headache |
| Carbon monoxide (CO)-induced headache |
| Alcohol-induced headache |
| Cocaine-induced headache |
| Histamine-induced headache |
| Calcitonin gene-related peptide (CGRP)-induced headache |
| Headache attributed to exogenous acute pressor agent |
| Headache attributed to occasional use of non-headache medication |
| Headache attributed to long-term use of non-headache medication |
| Headache attributed to use of or exposure to other substance |
| Medication-overuse headache (MOH) |
| Ergotamine-overuse headache |
| Triptan-overuse headache |
| Non-opioid analgesic-overuse headache |
| Opioid-overuse headache |
| Combination-analgesic-overuse headache |
| Medication-overuse headache attributed to multiple drug classes not individually overused |
| Medication-overuse headache attributed to unspecified or unverified overuse of multiple drug classes |
| Medication-overuse headache attributed to other medication |
| Headache attributed to substance withdrawal |
| Caffeine-withdrawal headache |
| Opioid-withdrawal headache |
| Oestrozen-withdrawal headache |
| Headache attributed to withdrawal from chronic use of other substance |
Modified by Headache Classification Committee of the International Headache Society (IHS) (25).